Skip to main content

Find Clinical Trials

Home
Conditions
Hypersensitivity, Immediate

Clinical trial condition

Hypersensitivity, Immediate

Explore clinical trials studying Hypersensitivity, Immediate. Study availability and eligibility vary by location and protocol.

6,751 public trials 635 recruiting studies

Refine in advanced search Browse all conditions

Hypersensitivity, Immediate trial results

Completed

Atopic Diseases & Human Papilloma Virus

NCT04397081

Conditions: Asthma, Atopic Asthma, Atopic Disorders, +18 more
Locations: Adana City Education and Research Hospital Adana, Merkez, Turkey (Türkiye)

View Trial Details

Completed

Evaluating Treatment Resistant Dermatitis TaroIIR

NCT03050294

Conditions: Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +11 more
Locations: Wake Forest University Health Sciences Department of Dermatology Winston-Salem, North Carolina, United States

View Trial Details

Completed

A Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis or Hereditary Periodic Fevers Who Participated in the CACZ885G2301E1, CACZ885G2306 or CACZ885N2301 Studies

NCT02334748

Conditions: Arthralgia, Arthritis, Arthritis, Juvenile, +55 more
Locations: Novartis Investigative Site Bron, France

Novartis Investigative Site Le Kremlin-Bicêtre, France

Novartis Investigative Site Paris, France

View Trial Details

Completed

E-support for Healthcare Processes - ASTHMA

NCT01461642

Conditions: Asthma, Bronchial Diseases, Hypersensitivity, +6 more
Locations: University Clinic of Pulmonary and Allergic Disease Golnik, Slovenia

View Trial Details

Completed

Study of Efficacy and Safety of QAW039 in Patients With Severe Asthma Inadequately Controlled With Standard of Care Asthma Treatment.

NCT02555683

Conditions: Asthma, Bronchial Diseases, Dyspnea, +11 more
Locations: Novartis Investigative Site Birmingham, Alabama, United States

Novartis Investigative Site Birmingham, Alabama, United States

Novartis Investigative Site Gilbert, Arizona, United States

Novartis Investigative Site Litchfield Park, Arizona, United States

View all 233 locations

View Trial Details

Completed

To Assess the Safety and Activity of GBR 830, Compared to Placebo, in Adults With Moderate-to-severe Atopic Dermatitis

NCT02683928

Conditions: Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations: Glenmark Investigational Site 14 Rogers, Arkansas, United States

Glenmark Investigational Site 5 Los Angeles, California, United States

Glenmark Investigational Site 3 San Diego, California, United States

Glenmark Investigational Site 15 Tampa, Florida, United States

View all 17 locations

View Trial Details

Completed

A Study To Determine The Safety, Tolerability, Skin Irritation Potential, And PK Following Topical Application Of PF-07038124 In Healthy Participants

NCT04135560

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis Atopic, +10 more
Locations: Pfizer New Haven Clinical Research Unit New Haven, Connecticut, United States

View Trial Details

Completed

Development and Validation of a Serum Biomarker for the Diagnostic Work-up of Asthma

NCT04377958

Conditions: Asthma, Biomarkers, Bronchial Diseases, +7 more
Locations: Not specified

View Trial Details

Completed

A Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Dose in Healthy Volunteers, Repeat Doses in Asthmatic Patients and of Single Dose in COPD Patients of CHF6366

NCT03378648

Conditions: Asthma, Bronchial Diseases, Chronic Disease, +12 more
Locations: Medicines Evaluation Unit Manchester, United Kingdom

View Trial Details

Completed

Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis

NCT02087943

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis, Atopic, +9 more
Locations: Arizona Research Center Phoenix, Arizona, United States

Bakersfield Dermatology and Skin Cancer Medical Group Bakersfield, California, United States

Dermatology Research Associates Los Angeles, California, United States

Renstar Medical Research Ocala, Florida, United States

View all 31 locations

View Trial Details